FDA Drug Application (021554) for CIPRO XR by BAYER PHARMS

Back to FDA Applications sponsored by BAYER PHARMS

Application Number021554
Product Number001
FormTABLET, EXTENDED RELEASE; ORAL
Dosage212.6MG; EQ 287.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCIPRO XR
Active IngredientCIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CIPROFLOXACIN10
List of drugs with Active Ingredient CIPROFLOXACIN HYDROCHLORIDE9


Back to FDA Applications sponsored by BAYER PHARMS